Clinical Trial: A Study to Evaluate the Pharmacokinetic Characteristics of HS-20118 Under Different Dosing Conditions in Healthy Participants

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07896915) titled 'A Study to Evaluate the Pharmacokinetic Characteristics of HS-20118 Under Different Dosing Conditions in Healthy Participants' on Oct. 13.

Brief Summary: This study is a single-center, open-label, randomized, four-period dosing clinical study designed to evaluate the pharmacokinetic characteristics of HS-20118 under different dosing conditions in healthy participants. It is planned to enroll 32 healthy participants.

Study Start Date: Aug. 03

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: HS-20118

HS-20118 tablets will be administered orally as a single dose of 400 mg (two 200 mg tablets) with a...